{"id":"https://openalex.org/W4361908877","doi":"https://doi.org/10.1158/1078-0432.22451643.v1","title":"Supplementary Methods and Figures and Tables from The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma","display_name":"Supplementary Methods and Figures and Tables from The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361908877","doi":"https://doi.org/10.1158/1078-0432.22451643.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22451643.v1","doi":"https://doi.org/10.1158/1078-0432.22451643.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451643.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.22451643.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052504518","display_name":"Toni K. Choueiri","orcid":"https://orcid.org/0000-0002-9201-3217","observed_orcids":["https://orcid.org/0000-0002-9201-3217"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toni K. Choueiri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077071889","display_name":"Andr\u00e9  Poisl Fay","orcid":"https://orcid.org/0000-0002-8588-7012","observed_orcids":["https://orcid.org/0000-0002-8588-7012"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9 P. Fay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076775426","display_name":"Robert J. Gagnon","orcid":"https://orcid.org/0009-0001-7339-3795","observed_orcids":["https://orcid.org/0009-0001-7339-3795"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Gagnon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036761448","display_name":"Ying Lin","orcid":"https://orcid.org/0000-0002-5923-3306","observed_orcids":["https://orcid.org/0000-0002-5923-3306","https://orcid.org/0000-0002-9299-756X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078216868","display_name":"Brittany Baham\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brittany Bahamon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Victoria Brown","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victoria Brown","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050435057","display_name":"Jonathan E. Rosenberg","orcid":"https://orcid.org/0000-0003-2637-4249","observed_orcids":["https://orcid.org/0000-0003-2637-4249"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan E. Rosenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102785664","display_name":"Thomas E. Hutson","orcid":"https://orcid.org/0000-0002-4529-4212","observed_orcids":["https://orcid.org/0000-0002-4529-4212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas E. Hutson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064655232","display_name":"Katherine L. Baker-Neblett","orcid":"https://orcid.org/0000-0001-6869-7498","observed_orcids":["https://orcid.org/0000-0001-6869-7498"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine L. Baker-Neblett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066680365","display_name":"Christopher F Carpenter","orcid":"https://orcid.org/0000-0001-5708-5381","observed_orcids":["https://orcid.org/0000-0001-5708-5381"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Carpenter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100390865","display_name":"Yuan Liu","orcid":"https://orcid.org/0000-0002-2923-3727","observed_orcids":["https://orcid.org/0000-0002-2923-3727"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuan Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064792807","display_name":"Lini N. Pandite","orcid":"https://orcid.org/0009-0005-9194-6348","observed_orcids":["https://orcid.org/0009-0005-9194-6348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lini Pandite","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046795494","display_name":"Sabina Signoretti","orcid":"https://orcid.org/0000-0002-5000-9105","observed_orcids":["https://orcid.org/0000-0002-5000-9105"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabina Signoretti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pazopanib","display_name":"pazopanib","score":0.9599999785423279},{"id":"https://openalex.org/keywords/metastatic-clear-cell-renal-cell-carcinoma","display_name":"metastatic clear cell renal cell carcinoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7459999918937683},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.6389999985694885},{"id":"https://openalex.org/keywords/gene-expression-patterns","display_name":"gene expression patterns","score":0.9120000004768372},{"id":"https://openalex.org/keywords/paraffin-embedded-tissue","display_name":"paraffin-embedded tissue","score":0.8109999895095825}],"concepts":[{"id":"https://openalex.org/C2778439243","wikidata":"https://www.wikidata.org/wiki/Q7157043","display_name":"Pazopanib","level":4,"score":0.9744917750358582},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.7143478989601135},{"id":"https://openalex.org/C2781278892","wikidata":"https://www.wikidata.org/wiki/Q18556340","display_name":"Clear cell renal cell carcinoma","level":3,"score":0.627214789390564},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5491046905517578},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5156904458999634},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.515626847743988},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5108053684234619},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22451643.v1","doi":"https://doi.org/10.1158/1078-0432.22451643.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451643.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22451643","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Methods_and_Figures_and_Tables_from_The_Role_of_Aberrant_VHL_HIF_Pathway_Elements_in_Predicting_Clinical_Outcome_to_Pazopanib_Therapy_in_Patients_with_Metastatic_Clear-Cell_Renal_Cell_Carcinoma/22451643","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22451643.v1","doi":"https://doi.org/10.1158/1078-0432.22451643.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451643.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6899999976158142,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2606889348","https://openalex.org/W4241936759","https://openalex.org/W2220116374","https://openalex.org/W2557225468","https://openalex.org/W1789292382","https://openalex.org/W3208685703","https://openalex.org/W2987552284","https://openalex.org/W3130606105","https://openalex.org/W4387606434","https://openalex.org/W3012319723"],"abstract_inverted_index":{"PDF":[0],"file,":[1],"296K,":[2],"The":[3],"role":[4],"of":[5,41],"aberrant":[6],"VHL/HIF":[7],"pathway":[8],"elements":[9],"in":[10,17],"predicting":[11],"clinical":[12],"outcome":[13],"to":[14],"pazopanib":[15],"therapy":[16],"patients":[18],"with":[19],"metastatic":[20],"clear-cell":[21],"renal":[22],"cell":[23],"carcinoma.":[24],"Figure":[25,29,38],"S1:":[26],"Study":[27],"design.":[28],"S2:":[30],"Heatmap":[31],"showing":[32],"4":[33],"potential":[34],"gene":[35],"expression":[36],"patterns.":[37],"S3:":[39],"Percentage":[40],"HIF2-alpha-positive":[42],"nuclei":[43],"compared":[44],"between":[45],"paraffin-dipped":[46],"and":[47],"non-paraffin-dipped":[48],"tissue":[49],"slides;":[50],"p=0.0004.":[51]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}